While the recent economic climate has generally affected most market sectors, cutbacks at hospitals and other healthcare centres, new regulatory policies and changes to reimbursement strategies are having a particularly strong effect on companies in the medical device sector.
In parallel, there are growing babyboomer healthcare needs, a marked transition of point of care towards the home environment and a variety of emerging markets to consider. This combination of changing market and user characteristics and increasing cost and price pressures mean that the underlying demand for innovative products and solutions is only going to increase. This innovation will now, more than ever, also need to result in cost effective products that demonstrate higher levels of usability and health effectiveness.
Why Sagentia?
- Experts in complex medical device developments that meet aggressive timescales
- Multidisciplinary and cross sector teams providing broad insights
- ISO 9001:2008 and ISO 13485:2003 accreditation
- Delivery of practical and commercial solutions that meet real user needs
- Deep science and technology expertise
- Customer friendly IP approach
- Bring global perspective and experience to projects and a worldwide delivery capability
With more than 25 years of experience working with clients as an end-end product development partner, Sagentia is well placed to help medical device companies respond to the industry’s challenges. We focus on delivering innovative medical products in four key areas: point of care diagnostics, surgical devices, and patient care.We have delivered innovation and value to a wide range of clients including: Johnson & Johnson, Astra Zeneca, St Jude, T2 Biosystems, Titan, Prosurgics and Photocure.